value and opportunity

valueandopportunity.com · 2026-10-26

Morningstar with a list of potentially undervalued luxury stocks Very interesting deep dive from Edelweiss Capital into the Question how AI Agents will influence OTAs (Booking etc.) Abbott Laboratories is planning a major spin-off in 2027 Thoughtful Q3 letter from Greenkeepers Asset Management Govro from Wintergems with an update on Champagne and other alcoholic spirit…

TickrTrends take: ABT trades at a valuation that TickrTrends currently classifies as undervalued within the Healthcare sector. A valuation-focused investor monitoring this stock should consider how the company's fundamental metrics compare to its peer group and whether the current price level reflects the full value of its business operations. Tracking any announcements related to pipeline developments, earnings revisions, or market conditions that could impact the risk-reward positioning of the company would be relevant to assessing whether the undervalued assessment persists.

Read the full story at valueandopportunity.com →